comparemela.com

Latest Breaking News On - Prnewswire kintara therapeutics inc - Page 5 : comparemela.com

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.

United statesSan diegoLincoln parkMike moyerIgnacio guerrero rosDavid schullRoberte hoffmanUs securities exchange commissionGlobal coalition for adaptive researchNational cancer instituteCompany current reports on formDrug administrationCompany quarterly reports on formSociety for neuroLincoln park capital fundCompany annual report on form

Kintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.

United statesSan diegoLincoln parkRoberte hoffmanListing qualification departmentNational cancer instituteUniversity hospital zurichGlobal coalition for adaptive researchCompany current reports on formCompany quarterly reports on formSociety for neuroLincoln park capital fundCompany annual report on formUs securities exchange commissionDrug administrationNasdaq stock market

Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) (Kintara or the Company), a biopharmaceutical company focused on the development of new solid tumor.

United statesSan diegoPacific heightsLincoln parkJules abrahamRoberte hoffmanGlobal coalition for adaptive researchNational cancer instituteCompany current reports on formCompany quarterly reports on formExchange commissionCompany annual report on formLincoln park capital fundPrnewswire kintara therapeutics incLincoln park capitalChief executive officer

Kintara Therapeutics to Present at the JMP Securities Life Sciences Conference

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.

United statesSan diegoJules abrahamRoberte hoffmanNational cancer instituteCompany current reports on formSecurities life sciences conferenceLotte new york palace hotelCompany quarterly reports on formCompany annual report on formPrnewswire kintara therapeutics incLife sciencesLotte new york palaceLife sciences conferenceGlioblastoma multiformeCutaneous metastatic breast cancer

Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.

United statesSan diegoJules abrahamListing qualification departmentNational cancer instituteNasdaq capital marketCompany current reports on formCompany quarterly reports on formNasdaq hearings panel theCompany annual report on formNasdaq stock marketPrnewswire kintara therapeutics incNasdaq listing ruleNasdaq hearings panelCutaneous metastatic breast cancerPrivate securities litigation reform act

vimarsana © 2020. All Rights Reserved.